Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care - Quiz - MDSpire

Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care

  • By

  • Yanfeng Song

  • Xiaofei Zhou

  • Lina Wang

  • June 9, 2026

Share

Original Source(s)

Outpatient step-up dosing of bispecific antibodies in relapsed or refractory multiple myeloma: an oncology nursing framework for monitoring and supportive care

  • by Yanfeng Song, Xiaofei Zhou, Lina Wang

  • June 9, 2026

Related Content

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee

Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence